Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Astressin-B can reverse and prevent hair loss in stressed mice.

CTHRC1 helps hair grow back, and plantar dermis mixture boosts it.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

CTP-543 is generally safe for treating alopecia areata.

Caribine from traditional Chinese medicine may help treat hair loss.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

CRH promotes fat production in skin cells, affecting conditions like acne.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Cepharanthine can block enterovirus entry and protect against infection.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Thallium poisoning is dangerous but treatable with specific medical interventions.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

CRH can cause hair loss by promoting cell death in hair growth cells.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Blocking certain brain processes reduces mating behavior in female rats.

CRH causes hair loss by reducing cell survival in hair follicles.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.